Completed PHASE2 INTERVENTIONAL 1-arm NCT00703521

Rabies Immunization Concomitant With JEV in Children

A Three-Year Clinical Study on Immunogenicity, Safety and Booster Response of Purified Chick Embryo Cell Rabies Vaccine (Pcecv) Administered Intramuscularly or Intradermally to 12- to 18-Month-Old Thai Children Concomitantly With Japanese Encephalitis Vaccine

Sponsor: Chiron company: Clinical Research and Medical Affairs

Conditions Rabies

Interventions Rabies vaccine

Updated 5 times since 2017 Last updated: Oct 23, 2008 Started: Aug 31, 2002 Primary completion: Oct 31, 2002 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Rabies and is currently completed. Chiron company: Clinical Research and Medical Affairs leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chiron company: Clinical Research and Medical Affairs
Mahidol University

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.